Effect of Recombinant Human Endostatin on Angiogenesis and Treatment Response of Chemoradiation Therapy for Patients With Esophageal Squamous Carcinoma
第一作者机构:[1]Sichuan Cancer Institute, Chengdu, China
推荐引用方式(GB/T 7714):
Li T.,Deng X.,Huang J.,et al.Effect of Recombinant Human Endostatin on Angiogenesis and Treatment Response of Chemoradiation Therapy for Patients With Esophageal Squamous Carcinoma[J].INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS.2014,90:S206-S206.doi:10.1016/j.ijrobp.2014.05.765.
APA:
Li, T.,Deng, X.,Huang, J.,Zhou, P.&Luo, H..(2014).Effect of Recombinant Human Endostatin on Angiogenesis and Treatment Response of Chemoradiation Therapy for Patients With Esophageal Squamous Carcinoma.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,90,
MLA:
Li, T.,et al."Effect of Recombinant Human Endostatin on Angiogenesis and Treatment Response of Chemoradiation Therapy for Patients With Esophageal Squamous Carcinoma".INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 90.(2014):S206-S206